Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Lyka Labs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1986 on BSE, Feb 1995 on NSE
Last close ₹75.07down ₹1.53 (2.00%)BSE ₹75.50
Share price at the NSE close on 2 Nov 2026. Previous close ₹76.60.
2 Nov: open ₹76.00, high ₹76.00, low ₹75.07
52-week range of traded prices to 2 Nov 2026
₹44.10Low, 30 Mar 2026₹96.00High, 6 Nov 2025
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹271 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.83
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,895
Lyka Labs share news and announcements
1,493 announcements, routine notices left out, newest first. Page 30 of 30.
Aug 2008
13 Aug · Board meeting
To consider the Audited Annual Accounts for the year ended March 31, 2008.
Jul 2008
31 Jul · Management
The Board of Directors at their meeting held on July 31, 2008 appointed Mr.D.G.Shah as Additional Director of the Company23 Jul · Board meeting
Meeting on 31 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”2 Jul · Management
Vide its letter dated July 02, 2008 that: "Mr. Piyush Hindia has been appointed as Company Secretary/Compliance Officer with immediate effect".
Jun 2008
11 Jun · Allotment of Equity Shares
Committee of Directors of the Company at their meeting held on June 11,2008 have allotted 6,50,000 Equity Shares of Rs.10/- each to the Promoters on conversion of 6,50,000 Equity Share Warrants at an excise price of Rs.41.50 mentioned under: (1) 3,25,000 Equity Shares to Kunal N. Gandhi. (2) 3,25,000 Equity Shares to N.L Gandhi HUF. Please note these warrants were allotted on December 12, 2006. All the above shares are locked in for a period of Three Years from the date of allotment of Equity Share Warrants i.e. upto 11.12.2009.2 Jun · Limited Review Report
Auditor's have conducted the limited review of the Unaudited financial results for the quarter ended March 31, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2008
2 May · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended March 31, 2008 (taken on record by the Board of Directors of the Company at its meeting held on April 30, 2008) that: Audit qualifications in respect of Audited Accounts for 2005-07 and management comments thereon are detailed below: (1) The deferment of R & D expenditure of Rs.1,61,14,667/- & GDR Issue expenses of Rs.91,61,542/- which is not in compliance with Accounting Standard (AS-26). The Company has explained at note no. 15 to the accounts.(2) Regarding non-provisions of arrears of ex-gratia at Rs.3,66,69,307/-, the matter presently is subjudice".
Apr 2008
17 Apr · Board meeting
Meeting on 30 Apr 2008: “Unaudited Financial Results for the qtr ended March 31, 2008”
Mar 2008
31 Mar · Allotment of Equity Shares
Vide its letter dated March 31, 2008 that "The Committee of Directors of the Company at their meeting held this morning have allotted 7,95,000 Equity Share to the Promoters on conversion of 7,95,0000 Equity Share Warrants as under: (1) 1,37,500 Equity shares of Rs.10/- each at a premium of Rs.31.50 to Kunal N. Gandhi. These shares are locked in for a period of Three Years from the date of allotment of Equity Share Warrants i.e. upto 11.12.2009. (2) 1,37,500 Equity shares of Rs.10/- each at a premium of Rs. 31.50 to N.I.Gandhi HUF. These shares are locked in for a period of Three Years from the date allotment of Equity Share Warrants i.e. upto 11.12.2009. (3) 5,20,000 Equity Shares of Rs.10/- each at a premium of Rs.45/- to N.I.Gandhi HUF. These shares are locked in for a period of Three Years from the date of allotment of Equity Share Warrants i.e. upto 21.12.2010".3 Mar · Limited Review Report
Auditor's have conducted the limited review of the Unaudited financial results for the nine months ended December 31, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2008
7 Feb · Company's Comments on Audit Qualifications
Vide notes to Accounts in the Unaudited Financial Results (Provisional) for the quarter ended December 31, 2007 (taken on record by the Board of Directors of the Company at its meeting held on January 31, 2008) regarding Audit qualifications in respect of Audited Accounts for 2005-07 and management comments thereon the details of which are as follows: a) The deferment of R&D expenditure of Rs. 1,61,14,667/- & GDR Issue expenses of Rs.91,61,542/- which is not in compliance with Accounting Standard (AS-26). The company has explained at note No.15 to the accounts; b) Regarding non-provision of arrears of ex-gratia at Rs. 3,66,69,307/-, the matter presently is subjudice.
Jan 2008
22 Jan · Board meeting
Meeting on 31 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Dec 2007
26 Dec · Management
Mrs. Vaishali Timmapur the Secretary of the Company has resigned from the services of the Company effective from the close of working hours of 24th December 200724 Dec · Allotment of shares/ warrants
Committee of Directors of the Company at their meeting held on December 22, 2007 have allotted 36,50,000 Equity Shares to Foreign Investor, Business Associates, Body Corporates and other Domestic Investors. The Committee also allotted 22,00,000 Equity share Warrants to the Promoters and Business Associates. The details of the allotment shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.10 Dec · Meeting
Proceedings of the Extra Ordinary General Meeting of the Company held on December 08, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Dec · Limited Review Report
Auditor's have conducted the limited review of the Un-Audited Financial Results for the quarter ended September 30, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
22 Nov · Meeting
Notice convening the Extra Ordinary General Meeting to be held on December 8, 2007 to consider the issue of Equity Shares / warrants on a Preferential Basis to Promoters/ Promoter Group, Foreign Investor, Business Associates, Financial Institutional Investors, Body Corporates and other Domestic Investors. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Nov · Business
At the meeting of the Board of Directors of the Company at its Meeting held on November 7, 2007, it was decided that the Company will issue upto 36,50,000 Equity Shares to Foreign investor/Business Associates/ Body Corporates and Other Domestic Investors at Rs.55/- per share on the terms and conditions as per the SEBI Guidelines on preferential issue dated August 4, 1994. The Board has also decided to issue 22,00,000 Equity Warrants to the Promoters and Business Associates at an exercise price of Rs.55/- per warrant on the terms and conditions as per the SEBI Guidelines on Preferential issue. The Chairman has been authorized to take necessary steps and to call an Extra Ordinary General Meeting to consider passing of the Special resolution under Section 81(1A) of the companies Act, 1956."
Oct 2007
31 Oct · Board meeting
To consider the issue of Financial Instruments on Preferential basis.24 Oct · Board meeting
Meeting on 31 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Sep 2007
11 Sep · Limited Review Report
Auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2007 . The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Sep · Meeting
Minutes of the proceedings of the Annual General Meeting held on August 27, 2007 and Speech delivered by the Chairman Shri. N. I. Gandhi at the Annual General Meeting of the Company held on August 27, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2007
8 Aug · Allotment of shares
Committee of Directors of the Company at their meeting held on August 03, 2007 have allotted to the Business Associates:- (1)10,00,000 Equity Shares of Rs.10/- each at a premium of Rs.33/- (Exercise price of Rs.43/- per share) and (2)3,00,000 Equity Share Warrants of Rs.10/- each at a premium of Rs.33/- (Exercise Price of Rs.43/-) to be converted into Equity Share with in 18 months from the date of allotment of the shares. The details of the allottees of Shares shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Aug · Corporate action
Lyka Labs Ltd had informed the Exchange that the Board of Directors at their meeting held on July 21, 2007 decided to hold the Annual General Meeting of the Company on August 27, 2007 and the Register of Members and Share Transfer Books will remain closed from August 17, 2007 to August 27, 2007 (both days inclusive). The Company has now informed the Exchange that: "The Revised Book Closure of Register of Members and Share Transfer Books is from Monday, the 20th August, 2007 to Monday, the 27th August, 2007 (both days inclusive) for the purpose of Annual General Meeting. The Company proposes to hold the 28th Annual General Meeting on Monday, the 27th August, 2007".
Jul 2007
31 Jul · Miscellaneous
Financial Highlights for the period ended 31st March 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Jul · Meeting
Proceedings of the Extra Ordinary General Meeting held on July 20, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Jul · Board meeting
Meeting on 31 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”23 Jul · Miscellaneous
Financial Highlights for the period 2005-07 for 18 months. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Jul · Meeting
Board of Directors at their meeting held on July 21, 2007 decided to hold the Annual General Meeting of the Company on August 27, 2007 and the Register of Members and Share Transfer Books will remain closed from August 17, 2007 to August 27, 2007 (both days inclusive).13 Jul · Board meeting
To consider the Audited Accounts for the 18 months from October 01, 2005 to March 31, 2007 and to consider other business matters.11 Jul · Meeting
Notice of the Extra-Ordinary General Meeting of the members of the Company to be held on July 20, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Jul · Conversion
July 05, 2007 that: "The Committee of Directors at their meeting held this evening has converted 2,10,000 Equity Share Warrants into 2,10,000 Equity Shares of Rs.10/- each at a premium of Rs.58/- (exercise price Rs.68/-) to the persons mentioned hereunder:- (1) Name of the allottee:- Kunal N. Gandhi (Promoter); No. of Shares:- 2,00,000, (2) Name of the allottee:- Tejal S. Parikh (Business Associate); No. of Shares:- 10,000".
Jun 2007
26 Jun · Resolutions
Resolution passed at the meeting of the Board of Directors of Lyka Labs Limited held on June 19, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Jun · Board meeting
At the meeting of the Board of Directors of the Company held this evening (June 19, 2007), it was decided that the Company will issue upto 10,00,000 Equity Shares to Business Associates/Domestic Body Corporates and Domestic Investors. The Board also decided to issue upto 3,00,000 Equity Share Warrants to Promoters / Business Associates. The pricing of the Equity Share / Warrants will be determined as per the Guidelines on Preferential issue dated 4th August, 1994 issued by SEBI (as amended up to date) and authorized the Chairman to take necessary steps in this behalf. An Extra Ordinary general meeting is being called to consider the passing of the Special resolution under Section 81(1A) of the Companies Act, 195612 Jun · Board meeting
Meeting of the Board of Directors of the Company will be held on June 19, 2007 to consider the issue of Financial Instruments on Preferential basis.7 Jun · Limited Review Report
Auditor's have conducted the limited review of the unaudited financial results for the eighteen months ended March 31, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2007
9 May · Audit Qualifications
Auditors' qualification with respect to Audited Accounts for 2004-05 and management comments thereon are as follows:- (I) Regarding non-transfer of balances amounting to Rs.46,23,454/- to the Investor Education Protection fund. The company is making efforts to deposit the same. (II)Regarding non-provision of debtors considered doubtful of recovery amounting to Rs.7,24,75,306/- and overdue sundry debtors of Rs.41,18,69,078/-. The Company is deciding on the option of either arriving at a claim settlement or write-off to an amount, after the follow-up is over and on knowing the outcome of litigation. (III) The deferment of R & D expenditure of Rs.64,05,135/- which is not in compliance with Accounting Standard (AS-26). The Company has explained at note no. 16 to the accounts. (IV) Regarding non-provisions of arrears of ex-gratia at Rs.4,00,16,044/-, the matter presently is subjudice.
Apr 2007
18 Apr · Board meeting
Meeting on 30 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”
Mar 2007
30 Mar · Conversion
Committee of Directors of the Company at their meeting held on March 30, 2007 have converted 3,75,000 Equity share Warrants into 3,75,000 Equity Shares at Rs. 10/- each at a premium of Rs. 31.50 per share (Exercise price Rs. 41.50 per warrant) to the persons mentioned hereunder : (1) Name of the allottee : Mr. Kunal Gandhi, No. of Warrants allotted : 187500, No. of shares allotted : 187500, Status : Promoter; (2) Name of the allottee : N.I Gandhi HUF, No. of Warrants allotted : 187500, No. of shares allotted : 187500, Status : Promoter.19 Mar · Limited Review Report
Auditor's have conducted the limited review of the unaudited financial results for the fifteen months ended December 31, 2006. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements). For more details click here.14 Mar · E-mail ID for Investor Complaints
We have designated the following e-mail ID for investor grievance redressal as investorredressal@lykalabs.com. The compliance officer for the purpose of redressal of the complaints is Ms. Vaishali Timmapur, Company Secretary.
Jan 2007
23 Jan · Board meeting
Meeting on 31 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”15 Jan · Conversion of Warrants
The Committee of Directors of the Company at their meeting held on 13/01/2007 have converted 2,50,000 Equity Share Warrants into 2,50,000 Equity Shares of Rs. 10/- each at a premium of Rs. 54/- per Share (Exercise Price Rs. 64/- per warrant) to the person mentioned hereunder :- (i) Name of the allottee - Mr. Kunal N Gandhi; No. of Warrants allotted - 1,00,000; No. of Share allotted - 1,00,000; Status - Promoter. (ii) Name of the allottee - Ms. Shrujal M Desai; No. of Warrants allotted - 1,00,000; No. of Share allotted - 1,00,000; Status - Business Associate. (iii) Name of the allottee - Swarna & Shwetha Stocks Private Limited; No. of Warrants allotted - 50,000; No. of Share allotted - 50,000; Status - Business Associate.